Radiopharm Theranostics earnings were -$29.7M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest RADX earnings report on Jun 30, 2024 announced Q2 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, RADX reported annual earnings of -$30.5M, with 25.8% growth.
Radiopharm Theranostics Earnings Reports & History FAQ
What were Radiopharm Theranostics's earnings last quarter?
Radiopharm Theranostics (NASDAQ: RADX) reported Q2 2024 earnings per share (EPS) of N/A, up N/A year over year. Total RADX earnings for the quarter were N/A. In the same quarter last year, Radiopharm Theranostics's earnings per share (EPS) was N/A.
Is Radiopharm Theranostics profitable or losing money?
As of the last Radiopharm Theranostics earnings report, Radiopharm Theranostics is currently losing money. Radiopharm Theranostics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$30.52 million, a 25.81% increase year over year.
What was RADX's earnings growth in the past year?
As of Radiopharm Theranostics's earnings date in Q1 2025, Radiopharm Theranostics's earnings has grown year over year. RADX earnings in the past year totalled -$29.73 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.